Spain · AEMPS CIMA
ALMOTRIPTAN CINFA 12,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 78686
- Form
- COMPRIMIDO RECUBIERTO CON PELÍCULA
- Composition / generic term
- almotriptán
- Source strength
- 12,5 mg
- Authorisation holder
- Laboratorios Cinfa S.A.
- Marketed in source snapshot
- Yes
Source-listed ingredients
- ALMOTRIPTAN — 12,5 mg
These values do not establish equivalence or a dose recommendation.
Packages
- ALMOTRIPTAN CINFA 12,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 3 comprimidos (Blister Al/Al)
- ALMOTRIPTAN CINFA 12,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 3 comprimidos (Blister PVC-Aluminio)
- ALMOTRIPTAN CINFA 12,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 4 comprimidos (Blister PVC-Aluminio)
- ALMOTRIPTAN CINFA 12,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 4 comprimidos (Blister Al/Al)
- ALMOTRIPTAN CINFA 12,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 6 comprimidos (Blister Al/Al)
- ALMOTRIPTAN CINFA 12,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 6 comprimidos (Blister PVC-Aluminio)
- ALMOTRIPTAN CINFA 12,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 9 comprimidos (Blister Al/Al)
- ALMOTRIPTAN CINFA 12,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 9 comprimidos (Blister PVC-Aluminio)
Source and coverage
- Professional information (original source)
- Patient leaflet (original source)
- Official document (original source)
Snapshot retrieved: 2026-09-18. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse Spain records →